Latest News about BNTX
Recent news which mentions BNTX
Global tally of COVID-19 cases nears 230 million, as President Biden hosts virtual summit on the pandemic and doubles U.S. purchase of Pfizer vaccine
September 22, 2021
From MarketWatch
The Daily Biotech Pulse: Pfizer-BioNTech US Vaccine Contract, Summit Slumps On Adverse Regulatory Feedback, Cerevel CFO Departs
September 22, 2021
From Benzinga
US To Donate Additional 500M Pfizer-BioNTech COVID-19 Vaccine Doses To Lower Income Nations
September 22, 2021
From Benzinga
Moderna's COVID Vaccine Could Be Better Than Pfizer's -- Here's Why Its Stock Isn't
September 22, 2021
From Motley Fool
Boosters And Mandate Could Increase Vaccine Demand
September 21, 2021
From Benzinga
FDA To Probably Decide On Pfizer/BioNTech COVID-19 Booster Shots By Tomorrow: Bloomberg
September 21, 2021
From Benzinga
Why Shares of Solid Biosciences Are Jumping Today
September 21, 2021
From Motley Fool
J&J says booster greatly improves COVID-19 vaccine efficacy as experts await FDA decision
September 21, 2021
From MarketWatch
Is Now the Time to Ditch Pharma Stocks?
September 21, 2021
From Motley Fool
The Smartest Stocks to Buy With $1,000 Right Now
September 21, 2021
From Motley Fool
Is Pfizer Stock a Buy After an FDA Panel Recommended Boosters for Ages 65 and Up?
September 21, 2021
From Motley Fool
Why Moderna Stock Is Falling Today
September 20, 2021
From Motley Fool
‘I’m a firm believer in science, but I’d still like to wait’: Pfizer’s vaccine results for kids might not lead to quick vaccinations
September 20, 2021
From MarketWatch
Why Pfizer Stock Holders Shouldn’t Obsess Over FDA Approval
September 20, 2021
From InvestorPlace
Pfizer, BioNTech Analysts On FDA Panel's COVID-19 Booster Dose Decision
September 20, 2021
From Benzinga
From Benzinga
Developed World Boosters Offer Big Market for Eventual Novavax Vaccine
September 20, 2021
From InvestorPlace
A Peek Into The Markets: US Stock Futures Signal Lower Start On Wall Street; Crude Oil Down 2%
September 20, 2021
From Benzinga
5 Stocks To Watch For September 20, 2021
September 20, 2021
From Benzinga
‘I decided I’d jump the gun’: What to consider before getting a booster shot if you’re not eligible yet
September 20, 2021
From MarketWatch
The Week Ahead In Biotech (Sept. 19-25): Incyte, Verrica FDA Decisions And Conference Presentations In The Spotlight
September 19, 2021
From Benzinga
Moderna's Bigger Catalyst: Full FDA Approval or Booster Authorization?
September 19, 2021
From Motley Fool
FDA Panel Votes Against Approval Of Pfizer/BioNTech's COVID-19 Booster Shot For General Public
September 17, 2021
From Benzinga
FDA committee votes against approving BioNTech and Pfizer’s COVID-19 booster
September 17, 2021
From MarketWatch
British Study To Test Mixed COVID-19 Vaccine Regime In Kids: Reuters
September 17, 2021
From Benzinga
Why COVID Vaccine Stocks BioNTech, Moderna, and Novavax Are Sliding While Ocugen Is Rising
September 17, 2021
From Motley Fool
WHO warns lack of COVID-19 vaccine supply in Africa could make it breeding ground for new variants and ‘send the whole world back to square one’
September 17, 2021
From MarketWatch
FDA Reveals COVID-19 Booster Advisory Committee Question
September 17, 2021
From Benzinga
The Daily Biotech Pulse: Adcom Tryst For Pfizer/BioNTech Booster Shot, AbCellera's COVID Antibody Treatment Gets Expanded Use, Protagonist Slapped With Clinical Hold
September 17, 2021
From Benzinga
Is Moderna Winning on Vaccine Efficacy?
September 17, 2021
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.